Award
National Institute of Neurological Disorders and Stroke 5R01NS127846-05
Therapies for Epilepsy Prevention - Focus on Adenosine
Recipient
Rutgers Biomedical and Health Sciences
Award Amount
$425,721.00
Ceiling
$425,721.00
Awarded
July 27, 2026
Identifier
5R01NS127846-05
A research project funded by NINDS to develop and test therapies for epilepsy prevention by targeting adenosine pathways using FDA-approved drugs and novel small molecules in rodent models.
Description
This project aims to test new interventional therapies to prevent epilepsy in rodent models of acquired epilepsy using existing FDA-approved drugs. It focuses on targeting adenosine receptor-dependent and independent mechanisms and testing combination therapies to prevent epileptogenesis.